Table_4_Impacts of smoking on alcoholic liver disease: a nationwide cohort study.docx by Jeong-Ju Yoo (3666826)

“…Objectives<p>Smoking is a preventable risk factor for morbidity and mortality in patients with liver disease. …”

Table_2_Impacts of smoking on alcoholic liver disease: a nationwide cohort study.docx by Jeong-Ju Yoo (3666826)

“…Objectives<p>Smoking is a preventable risk factor for morbidity and mortality in patients with liver disease. …”

Table_1_Impacts of smoking on alcoholic liver disease: a nationwide cohort study.docx by Jeong-Ju Yoo (3666826)

“…Objectives<p>Smoking is a preventable risk factor for morbidity and mortality in patients with liver disease. …”

Image_2_Impacts of smoking on alcoholic liver disease: a nationwide cohort study.pdf by Jeong-Ju Yoo (3666826)

“…Objectives<p>Smoking is a preventable risk factor for morbidity and mortality in patients with liver disease. …”

Table_3_Impacts of smoking on alcoholic liver disease: a nationwide cohort study.docx by Jeong-Ju Yoo (3666826)

“…Objectives<p>Smoking is a preventable risk factor for morbidity and mortality in patients with liver disease. …”

Apoptosis inhibition by <i>Simkania</i> is a function of time and infection dose and is independent of the stimulus. by Karthika Karunakaran (212688)

“…<p>(<b>A</b>) Immunofluorescence analysis of the time and dose dependency of <i>Simkania</i> mediated anti-apoptosis. …”

Image_1_Impacts of smoking on alcoholic liver disease: a nationwide cohort study.pdf by Jeong-Ju Yoo (3666826)

“…Objectives<p>Smoking is a preventable risk factor for morbidity and mortality in patients with liver disease. …”

Table_5_Impacts of smoking on alcoholic liver disease: a nationwide cohort study.docx by Jeong-Ju Yoo (3666826)

“…Objectives<p>Smoking is a preventable risk factor for morbidity and mortality in patients with liver disease. …”

Visibility of the rhabdomeric membrane from the soma and membrane capacitance. by Roman V. Frolov (9647905)

Absolute and relative cardiomyopathy and myocarditis DALYs rate attributable to 2^nd level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Absolute and relative ischaemic heart disease DALYs rate attributable to 2^nd level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Absolute and relative stroke DALYs rate attributable to 2^nd level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Absolute and relative overall CVD DALYs rate attributable to 2^nd-level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Absolute and relative atrial fibrillation and flutter DALYs rate attributable to 2^nd level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Absolute and relative hypertensive heart disease DALYs rate attributable to 2^nd level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Absolute and relative aortic aneurysm DALYs rate attributable to 2^nd level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Absolute and relative overall CVD DALYs rate attributable to 1^st-level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Urinary Na⁺ concentration ([Na⁺]_ur). by Amaury Pereira-Acácio (591234)

Effect of plasmid DNA methylation on <i>PPP2R1A</i> promoter activity. by Hui-Feng Chen (325652)

“…</b> The CpG islands of the 5′-flanking region of <i>PPP2R1A</i>. The region from −400 nt to +105 nt was identified as a CpG island using the CpG finder at EMBL (<a href="http://www.ebi.ac.uk/" target="_blank">http://www.ebi.ac.uk/</a>) and the following parameters: CpG length >200 bp, G+C >50% and a “CpG value” of at least 0.6. …”

Primer sequence information used in this study. by Ruijuan Zhuang (3938915)